Truist Financial Corp grew its holdings in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 13.9% in the 4th ...

IDEXX Laboratories is poised for growth in the pet healthcare market. Check out why I see a 50% upside in IDXX stock by FY27.

IDEXX Laboratories, Inc.’s IDXX fourth-quarter performance was driven by the consistent strong performance of the Companion Animal Group (“CAG”) segment. Solid performance in the international markets ...

Savant Capital LLC lowered its position in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX – Free Report) by 14.4% in the 4th ...

Is IDEXX Laboratories a good investment? Analyzing its consistent growth, innovative products, and international expansion ...

Investors in IDEXX Laboratories, Inc. IDXX need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 21, 2025 $290.00 Call had some of the highest ...

Shares of IDEXX Laboratories Inc. IDXX rallied 1.02% to $449.06 Tuesday, on what proved to be an all-around positive trading ...

At Stock Options Channel, our YieldBoost formula has looked up and down the IDXX options chain for the new September 19th contracts and identified one put and one call contract of particular interest.

IDEXX Laboratories, Inc. IDXX has unveiled the IDEXX Cancer Dx ... development to positively boost market sentiment toward the stock. IDEXX currently has a market capitalization of $35.26 billion.